Welcome to LookChem.com Sign In|Join Free

CAS

  • or

175481-26-2

Post Buying Request

175481-26-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

175481-26-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 175481-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,4,8 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 175481-26:
(8*1)+(7*7)+(6*5)+(5*4)+(4*8)+(3*1)+(2*2)+(1*6)=152
152 % 10 = 2
So 175481-26-2 is a valid CAS Registry Number.

175481-26-2Relevant articles and documents

High-efficiency racemic lacosamide preparation method

-

Paragraph 0039; 0040; 0041; 0042; 0043; 0044; 0045-0058, (2018/08/04)

The invention discloses a high-efficiency racemic lacosamide preparation method. The preparation method is characterized in that N-acetyl serine shown in a formula (II) is utilized as a raw material and completely reacts with methyl bromide under the action of sodium hydride to obtain 2-acetamido-3-methoxy methyl propionate shown in a formula (III), and then the 2-acetamido-3-methoxy methyl propionate generates ester exchange reaction with benzylamine under the catalyst of trifluoromethanesulfonate to obtain a product namely racemic lacosamide. The suspended lacosamide preparation method disclosed by the invention has an industrial process route which has the advantages of short reaction line, high yield, high atom utilization rate, simpleness in aftertreatment and low cost.

PROCESS FOR THE SYNTHESIS OF LACOSAMIDE

-

Page/Page column 7, (2011/08/21)

A novel process for the synthesis of Lacosamide using D,L-serine as starting material is described, where the methylation reaction of hydroxyl is carried out using an inexpensive base such as NaOH and an inexpensive alkylating agent, non-toxic and non-car

Anticonvulsant enantiomeric amino acid derivatives

-

, (2008/06/13)

The present invention is directed to a compound in the R configuration about the asymmetric carbon in the following formula: STR1 pharmaceutical compositions containing same and the use thereof in treating CNS disorders in animals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 175481-26-2